Abstract
Vacuolar myelopathy is a common neurological complication in AIDS patients. The pathogenesis of this spinal cord white matter disease remains unclear and it is still debated whether infection of spinal cord with the human immunodeficiency virus type 1 (HIV–1) is causing the disease. We have generated transgenic mice expressing the entire HIV–1 genome under the regulation of an oligodendrocyte–specific promoter. These mice develop spinal cord vacuolar lesions similar to those found in AIDS patients. This animal model provides in vivo evidence linking the expression of HIV–1 proteins in oligodendrocytes to the spinal cord damage found in vacuolar myelopathy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Goldstick, L., Mandybur, T.I. & Bode, R. Spinal cord degeneration in AIDS. Neurology 35, 103–106 (1985).
Petito, C.K. et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 312, 874–879 (1985).
Artigas, J., Grosse, G. & Niedobitek, F. Vacuolar myelopathy in AIDS. A morphological study. Pathol. Res. Pract. 186, 228–237 (1990).
Bergmann, M., Gullotta, F., Kuchelmeister, K., Masini, T. & Angeli, G. AIDS-myelopathy: A neuropathological study. Pathol. Res. Pract. 189, 58–65 (1993).
Eilbott, D.J. et al. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophages. Proc. Natl. Acad. Sci. USA 86, 3337–3341 (1989).
Weiser, B. et al. Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. Proc. Natl. Acad. Sci. USA 87, 3997–4001 (1990).
Tyor, W.R. et al. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43, 1002–1009 (1993).
Rosenblum, M. et al. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology 39, 892–896 (1989).
Grafe, M.R. & Wiley, C.A. Spinal cord and peripheral nerve pathology in AIDS: The roles of cytomegalovirus and human immunodeficiency virus. Ann. Neurol. 25, 561–566 (1989).
Hénin, D., Smith, T.W., De Girolami, U., Sughayer, M. & Hauw, J.-J. Neuropathology of the spinal cord in the acquired immunodeficiency syndrome. Hum. Pathol. 23, 1106–1114 (1992).
Petito, C.K., Vecchio, D. & Chen, Y.T. HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy. J. Neuropathol. Exp. Neurol. 53, 86–94 (1994).
Kamin, S. & Petito, C.K. Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patients. Hum. Pathol. 22, 816–824 (1991).
Koenig, S. et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089–1093 (1986).
Wiley, C.A., Schrier, R.D., Nelson, J.A., Lampert, P.W. & Oldstone, M.B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83, 7089–7093 (1986).
Vazeux, R. et al. AIDS subacute encephalitis: Identification of HIV-infected cells. Am. J. Pathol. 126, 403–410 (1987).
Budka, H. & Lassmann, H. Human immunodeficiency virus in glial cells? J. Infect. Dis. 157, 203 (1988).
Sharer, L. & Prineas, J.W. Human immunodeficiency virus in glial cells [continued]? J. Infect. Dis. 157, 204 (1988).
Gosztonyi, G., Artigas, J., Lamperth, L. & Webster, H.D. Human immunodeficiency virus (HIV) distribution in HIV encephalitis: Study of 19 cases with combined use of in situ hybridization and immunocytochemistry. J. Neuropathol. Exp. Neural. 53, 521–534 (1994).
Nuovo, G.J., Gallery, F., MacConnell, P. & Braun, A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 144, 659–666 (1994).
Korber, B.T. et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68, 7467–7481 (1994).
Gyorkey, F., Melnick, J.L. & Gyorkey, P. Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J. Infect. Dis. 155, 870–876 (1987).
Staler, M.H., Eskin, T.A., Benn, S., Angerer, R.C. & Angerer, L.M. Human T-cell lymphotropic virus type HI infection of the central nervous system. A preliminary in situ study. JAMA 256, 2360–2364 (1986).
Pumarola-Sune, T., Navia, B.A., Cordon-Cardo, C., Cho, E.S. & Price, R.W. HIV antigen in the brains of patients with the AIDS dementia complex. Ann. Neural. 21, 490–496 (1987).
Esiri, M., Morris, C.S. & Miliard, P.R. Fate of oligodendrocytes in HIV-1 infection. AIDS 5, 1081–1088 (1991).
Bagasra, O. et al. Cellular reservoirs of HIV-1 in the central nervous system of infected-individuals: Identification by the combination of in situ PCR and immunohistochemistry. AIDS (in the press).
Embretson, J. et al. Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc. Natl. Acad. Sci. USA 90, 357–361 (1993).
Adachi, A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284–291 (1986).
Katsuki, M. et al. Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice. Science 241, 593–595 (1988).
Allinquant, B., Staugaitis, S.M., D'Urso, D. & Colman, D.R. The ectopic expression of myelin basic protein isoforms in shiverer oligodendrocytes: Implications for myelinogenesis. J. Cell Biol. 113, 393–403 (1991).
Yoshioka, T., Feigenbaum, L. & Jay, G. Transgenic mouse model for central nervous system demyelination. Mol. Cell. Biol. 11, 5479–5486 (1991).
Turnley, A.M. et al. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 353, 566–569 (1991).
Allan, J.S. et al. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230, 810–813 (1985).
Arya, S.K. & Gallo, R.C. Three novel genes of human T-lymphotropic virus type III: Immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83, 2209–2213 (1986).
Toggas, S.M. et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367, 188–193 (1994).
Saito, Y. et al. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44, 474–481 (1994).
Tornatore, C., Chandra, R., Berger, J.R. & Major, E.O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44, 481–487 (1994).
Ranki, A. et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 5, 1001–1008 (1995).
Green, R., van Tonder, S.V., Oettle, G.J., Cole, G. & Metz, J. Neurological changes in fruit bats deficient in vitamin B12 . Nature 254, 148–150 (1975).
Scalabrino, G. et al. Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Lab. Invest. 72, 114–123 (1995).
Takahashi, N., Roach, A., Teplow, D.B., Prusiner, S.B. & Hood, L. Cloning and characterization of the myelin basic protein gene from mouse: One gene can encode both 14 kD and 18.5 kD MBPs by alternate use of exons. Cell 42, 139–148 (1985).
Bouchard, L., Lamarre, L., Tremblay, P.J. & Jolicoeur, P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57, 931–936 (1989).
Sambrook, J., Frisch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd edn. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).
Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159 (1987).
McLean, I.W. & Nakane, P.K. Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22, 1077–1083 (1974).
Gravel, C., Kay, D.G. & Jolicoeur, P. Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J. Virol. 67, 6648–6658 (1993).
Jolicoeur, P., Laperrière, A. & Beaulieu, N. Efficient production of human immunodeficiency virus proteins in transgenic mice. J. Virol. 66, 3904–3908 (1992).
Thomas, F.P., Chalk, C., Lalonde, R., Robitaille, Y. & Jolicoeur, P. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J. Virol. 68, 7099–7107 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goudreau, G., Carpenter, S., Beaulieu, N. et al. Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter. Nat Med 2, 655–661 (1996). https://doi.org/10.1038/nm0696-655
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0696-655
This article is cited by
-
Delineating HIV-Associated Neurocognitive Disorders Using Transgenic Models: The Neuropathogenic Actions of Vpr
Journal of Neuroimmune Pharmacology (2012)
-
Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau
Journal of Neurocytology (2005)
-
Recent advances in amyotrophic lateral sclerosis research
Current Neurology and Neuroscience Reports (2003)